Vice Mayor Xu Hui and his delegation visited the Boda Weiye Changchun Institute of Pharmaceutical Research for inspection and research.


Release date:

2020-09-18

To deeply implement Jilin Province's strategy for promoting high-quality development of the pharmaceutical and healthcare industry, and actively respond to the province’s industrial spatial layout under the "One Main, Six Duals" initiative for building a pharmaceutical and healthcare industry corridor, the province aims to transform the pharmaceutical and healthcare sector—from a traditional strength—into a new pillar industry that will receive key support during the 13th Five-Year Plan period and beyond. On the afternoon of July 13, Xu Hui, Vice Mayor of Liaoyuan City, along with his delegation, visited our company’s Changchun Institute of Pharmaceutical Research to explore and assess potential opportunities for establishing a new R&D platform focused on chemical drugs in Liaoyuan City. Accompanying the delegation were Chairman Duan Chengjun, General Manager Xie Wenbo, and other senior company leaders who joined the inspection and discussion. The vice mayor and his team toured the company’s flagship products, cutting-edge R&D instruments and equipment, as well as specialized scientific research tools, gaining valuable insights into the company’s product development processes and innovations. Following the tour, the delegation held a cordial meeting with the company’s leadership. During the meeting, Chairman Duan and General Manager Xie warmly welcomed Vice Mayor Xu and provided an overview of the company’s growth trajectory, highlighting its robust R&D capabilities, advanced production technologies, and clear strategic direction. They also emphasized: First, the company remains steadfastly committed to R&D as its technological cornerstone, continuously building a comprehensive R&D value chain; Second, the company boasts a highly skilled R&D team with extensive project development expertise and multiple mature technology platforms, enabling it to collaborate effectively with numerous pharmaceutical companies, clinical research institutions, and academic partners; Third, they expressed their aspiration for the company to play an active role in bolstering Liaoyuan City’s pharmaceutical industry development. Vice Mayor Xu commended Bo Da Wei Ye on its remarkable achievements over recent years, engaging in in-depth discussions about potential collaborative initiatives. He also shared invaluable insights aimed at supporting the company’s continued growth and expansion.

To deeply implement Jilin Province's strategy for promoting high-quality development of the pharmaceutical and healthcare industry, and actively respond to the province’s industrial spatial layout under the "One Core, Six Pairs" initiative for building the pharmaceutical and healthcare industry corridor, the province aims to transform the pharmaceutical and healthcare sector—from a traditionally strong industry—into a new pillar industry that will be prioritized for cultivation during the 13th Five-Year Plan period and beyond.

7 On the afternoon of the 13th, A delegation led by Xu Hui, Vice Mayor of Liaoyuan City Visit our company's Changchun Institute of Pharmaceutical Research Field Study and Investigation To explore and visit the newly established R&D platform for chemical pharmaceuticals in Liaoyuan City, Chairman Duan Chengjun, General Manager Xie Wenbo, and other company leaders accompanied the delegation during the inspection and research trip.

Vice Mayor Xu and his delegation toured the company’s key products, R&D instruments and equipment, as well as scientific research apparatus, and engaged in insightful consultations while gaining a deeper understanding of our company’s product development efforts.

 

Following this, Vice Mayor Xu and his delegation held a symposium with the company's leadership.

At the symposium, General Manager Duan and General Manager Xie first welcomed Vice Mayor Xu and his delegation, introducing them to the company's overall development profile, R&D initiatives, production processes, and future growth directions—while emphasizing:

1. The company has consistently adhered to R&D as its technological core, establishing a comprehensive R&D value chain.

2. The company boasts a professional R&D team, extensive project development experience, and multiple mature technology platforms. It has already established broad collaborations with numerous pharmaceutical companies, clinical research institutions, and academic research universities.

III. We hope the company can contribute to the development of the pharmaceutical industry in Liaoyuan City.

Vice Mayor Xu expressed high appreciation for the achievements Boda Weiye has made in recent years, engaging in in-depth discussions on relevant cooperation matters. At the same time, Vice Mayor Xu shared valuable insights to support the company’s further growth and development.

Keywords:

Research, Company, Vice Mayor, R&D, Delegation, Industry, Pharmaceuticals, Inspection, In-depth, Development